Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1804463
Name of medicinal product: Cryptisel
Active substances:
Halofuginone
Estonian, English, Latin
ATC code: QP51BX01
Dosage form: oral solution
Route of administration: oral use
Strengh: 0,5mg 1ml
Amount in package: 490ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Prevention of diarrhoea due to diagnosed Cryptosporidium parvum, in farms with history of cryptosporidiosis. Administration should start in the first 24 to 48 hours of age. Reduction of diarrhoea due to diagnosed Cryptosporidium parvum. Administration should start within 24 hours after the onset of diarrhoea. In both cases, the reduction of oocysts excretion has been demonstrated.
Safety features: No
Summary of product characteristics (SPC):  (last updated 31 March 2023)
Package information leaflet (PIL): EST  (last updated 02 November 2020)
Labelling:  (last updated 02 November 2020)
Withdrawal time: Lihale ja söödavatele kudedele: 13 päeva.
Species: veis (vasikas)
Last imported to Estonia: 02 February 2024
Marketing authorization holder: Livisto Int'l S.L. 
Marketing authorization number: 2258 
Marketing authorization issued on: 02 November 2020 
Marketing authorization expires on: 02 November 2025 
Marketing authorization procedure type: Decentralised 
Entry/Changing date: 31 March 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription